Leerink Partners Cuts Price Target on Wright Medical Group (WMGI) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/16/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- U.S. Commerce Department to sell up to 9.9M GlobalFoundries shares
- AI chip sell-off overblown: Zero GPU slowdown after Anthropic essay, analyst says
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Wall Street ends lower as oil spikes and the benchmark Treasury yield breaches 5%
Wright Medical Group N.V. Announces Entry Into Metal-On-Metal Hip Litigation Settlement Agreement
November 2, 2016 4:06 PM EDTAMSTERDAM, The Netherlands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that on November 1, 2016, its wholly owned subsidiary Wright Medical Technology, Inc. (WMT) entered into a Master Settlement Agreement (MSA) with Court-appointed attorneys representing plaintiffs in the previously disclosed metal-on-metal hip multi-district litigation known as In Re: Wright Medical Technology, Inc., CONSERVE® Hip Implant Products Liability Litigation, MDL No. 2329 (MDL) and the consolidated proceeding pending in state court in California known as In re: Wright Hip System Cases, Judicial Council Coordination Proceeding No. 4710 (JCCP).  In addition, on October... More
Wright Medical Group N.V. Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance
November 2, 2016 4:06 PM EDTÂ Â Third Quarter 2016 Net Sales From Continuing Operations of $157 Million As Reported
Third Quarter 2016 Global Extremities and Biologics Net Sales Increased 96%, Driven By Year over Year Impact from Tornier Merger, and 9% on a Non-GAAP Pro Forma Constant Currency Basis
Third Quarter 2016 Net Loss From Continuing Operations of $53 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $6 Million
Company Reaches Settlement Agreement in Metal-On-Metal Hip Litigation
AMSTERDAM, The Netherlands, Nov. 02, 2016 (GLOBE NEWSWIRE)... More
